Search by Drug Name or NDC

    NDC 17156-0235-01 AdreView 2 mCi/mL Details

    AdreView 2 mCi/mL

    AdreView is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medi-Physics Inc.. The primary component is IOBENGUANE I-123.

    Product Information

    NDC 17156-0235
    Product ID 17156-235_44cadee9-19ca-4756-ab85-0836b38db89f
    Associated GPIs 94354050102020
    GCN Sequence Number 068315
    GCN Sequence Number Description iobenguane sulfate I-123 VIAL 10 MCI/5ML INTRAVEN
    HIC3 P5F
    HIC3 Description ADRENAL RADIOACTIVE DIAGNOSTICS
    GCN 31077
    HICL Sequence Number 038326
    HICL Sequence Number Description IOBENGUANE SULFATE I-123
    Brand/Generic Brand
    Proprietary Name AdreView
    Proprietary Name Suffix n/a
    Non-Proprietary Name Iobenguane I-123
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mCi/mL
    Substance Name IOBENGUANE I-123
    Labeler Name Medi-Physics Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022290
    Listing Certified Through 2025-12-31

    Package

    NDC 17156-0235-01 (17156023501)

    NDC Package Code 17156-235-01
    Billing NDC 17156023501
    Package 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS
    Marketing Start Date 2008-09-19
    NDC Exclude Flag N
    Pricing Information N/A